Skip to content
Laurent Pharma
  • ABOUT US
    • Leadership
    • Board of directors
  • SCIENCE
    • LAU-7b
  • CONTACT
  • ABOUT US
    • Leadership
    • Board of directors
  • SCIENCE
    • LAU-7b
  • CONTACT

News

Laurent Pharmaceuticals featured in Biotech Finances

  • Post published:18 July 2016

Laurent Pharmaceuticals featured in Biotech Finances. Read the article

Continue ReadingLaurent Pharmaceuticals featured in Biotech Finances

Laurent Pharmaceuticals to receive investment from Cystic Fibrosis Canada

  • Post published:17 March 2016

Laurent Pharmaceuticals Inc. announced today the closing of a financing round led by Cystic Fibrosis Canada. Existing investors Aligo Innovation LP (previously MSBi Valorisation) and members of Anges Quebec, as…

Continue ReadingLaurent Pharmaceuticals to receive investment from Cystic Fibrosis Canada

Laurent Pharmaceuticals featured in BioCentury Magazine

  • Post published:15 September 2015

Laurent Pharmaceuticals Inc. announced today that the LAU-7b program addressing aberrant inflammation is featured in the September 14th issue of BioCentury, one of the most widely read publications in the pharma industry. Published under…

Continue ReadingLaurent Pharmaceuticals featured in BioCentury Magazine
← Newer Posts
Older Posts →
  • ABOUT US
    • Leadership
    • Board of directors
  • SCIENCE
    • LAU-7b
  • CONTACT

CONTACT

  • Address:1010 Sherbrooke St West, Suite 2401 Montréal (Québec) H3A 2R7 Canada
  • Email:info@laurentpharma.comOpens in your application
Laurent Pharmaceuticals Inc. © 2025 All Rights Reserved.